Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
National Institutes of Health
- Funding range
- $0 – $450K
- Application window
- Opens: Not listed
- Closes: July 16, 2029
- Applications Status:Upcoming
- Location
- National
Source & verification
- Original funding source
- www.grants.gov
- Last checked
- October 28, 2026
- Last reviewed by Ryplle
- Not yet recorded
Source checks may be automated. Review dates reflect a recorded staff review. Confirm current requirements with the funder.
Eligibility at a glance
- Listed applicant types
- Nonprofit, Student, Business
- Geographic eligibility
- National
- Matching funds
- Not specified — check with the funder
- Major exclusions
- Not specified — check with the funder
Listed types are not a determination of eligibility. The funder’s full requirements take precedence.
Full eligibility requirements
Eligible applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public and State controlled institutions of higher education; Special district governments; State governments; For profit organizations other than small businesses; City or township governments; Private institutions of higher education; Small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County governments; Public housing authorities/Indian housing authorities; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments).
About this grant
The purpose of this notice of funding opportunity (NOFO) is to support pilot and feasibility studies to inform the design and conduct of efficacy, effectiveness, and/or services research trials. Topics may include: 1) developing interventions to prevent substance use, misuse, or progression to substance use disorder; 2) prevention, treatment, or recovery services research, including research addressing comorbid pain and medical and mental health disorders; and 3) HIV eradication research, including implementation science, prevention, treatment and recovery in substance use settings/populations.
Contact information
- National Institutes of Health
- pilotstudies@mail.nih.gov
- 301-402-2541